NCT00000392View on ClinicalTrials.gov

Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.

PHASE2CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

January 31, 1990

Primary Completion Date

August 31, 1996

Study Completion Date

August 31, 1996

Conditions
HIV InfectionsCognition Disorders
Interventions
DRUG

Peptide T

DRUG

Placebo

Trial Locations (3)

33136

Univ of Miami School of Medicine, Miami

90033

Los Angeles County - USC Med Ctr, Los Angeles

92103

UCSD, San Diego

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH